Graft Versus Host Disease [clinicaltrials_resource:127491dc7fac5533c4bc11d9fcc5f1d4]
Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00002456]Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [clinicaltrials:NCT00002790]clinicaltrials:NCT00002833Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation [clinicaltrials:NCT00003056]Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003270]clinicaltrials:NCT00003335Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003398]Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00003414]Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003661]Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases [clinicaltrials:NCT00003662]Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant [clinicaltrials:NCT00003894]Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease [clinicaltrials:NCT00004194]Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00004232]Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00004255]Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00004878]Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00004904]Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00005641]Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant [clinicaltrials:NCT00005852]Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy [clinicaltrials:NCT00005988]Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies [clinicaltrials:NCT00006054]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders [clinicaltrials:NCT00006056]Bone Marrow Transplantation in Treating Patients With Leukemia [clinicaltrials:NCT00006451]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma [clinicaltrials:NCT00006747]Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation [clinicaltrials:NCT00007059]Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon [clinicaltrials:NCT00010283]Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer [clinicaltrials:NCT00014469]Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00017654]clinicaltrials:NCT00031824Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease [clinicaltrials:NCT00043147]Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia [clinicaltrials:NCT00053157]Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease [clinicaltrials:NCT00053976]Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder [clinicaltrials:NCT00054340]Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract [clinicaltrials:NCT00055666]Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants [clinicaltrials:NCT00056875]clinicaltrials:NCT00074035Sirolimus as Secondary Therapy in Treating Patients With Chronic Graft-Versus-Host Disease That Did Not Respond To Prior Treatment [clinicaltrials:NCT00079183]OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies [clinicaltrials:NCT00081055]Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [clinicaltrials:NCT00089037]Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia [clinicaltrials:NCT00093587]
condition [clinicaltrials_vocabulary:condition]
Graft Versus Host Disease [clinicaltrials_resource:127491dc7fac5533c4bc11d9fcc5f1d4]
Bio2RDF identifier
127491dc7fac5533c4bc11d9fcc5f1d4
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:127491dc7fac5533c4bc11d9fcc5f1d4
identifier
clinicaltrials_resource:127491dc7fac5533c4bc11d9fcc5f1d4
title
Graft Versus Host Disease
@en
label
Graft Versus Host Disease [clinicaltrials_resource:127491dc7fac5533c4bc11d9fcc5f1d4]
@en